123 related articles for article (PubMed ID: 6831473)
1. Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans.
Sasaki T; Abiko N; Uchida H; Tanaka M; Nitta K; Yoshioka Y; Nomura H
Cancer Treat Rep; 1983 Mar; 67(3):275-80. PubMed ID: 6831473
[TBL] [Abstract][Full Text] [Related]
2. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
Sasaki T; Abiko N; Sugino Y; Nitta K
Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of antitumor activity and immunomodulatory effect of tetrahydro-2-furanyl and tetrahydro-2-pyranyl (1 leads to 3)-beta-D-glucans.
Uchida H; Sasaki T
J Pharmacobiodyn; 1983 Sep; 6(9):660-7. PubMed ID: 6655547
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140.
Sasaki T; Abiko N; Nitta K; Takasuka N; Sugino Y
Eur J Cancer (1965); 1979 Feb; 15(2):211-5. PubMed ID: 436898
[No Abstract] [Full Text] [Related]
5. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
Morikawa K; Takeda R; Yamazaki M; Mizuno D
Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
[TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative pathway of complement by an antitumor (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140, and its lower molecular weight and carboxymethylated derivatives.
Honda S; Sugino H; Asano T; Kakinuma A
Immunopharmacology; 1986 Feb; 11(1):29-37. PubMed ID: 3957648
[TBL] [Abstract][Full Text] [Related]
7. A cleavage product of mouse C3 adsorbable to (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140.
Matsushita M; Sankawa U; Okuda T; Okada H; Sasaki T
Jpn J Exp Med; 1983 Oct; 53(5):219-25. PubMed ID: 6206261
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of cell wall beta-1,3/1,6-glucans from Phytophthora species.
Kraus J; Blaschek W; Schütz M; Franz G
Planta Med; 1992 Feb; 58(1):39-42. PubMed ID: 1620741
[TBL] [Abstract][Full Text] [Related]
9. Molecular mass and antitumor activities of sulfated derivatives of alpha-glucan from Poria cocos mycelia.
Lin Y; Zhang L; Chen L; Jin Y; Zeng F; Jin J; Wan B; Cheung PC
Int J Biol Macromol; 2004 Oct; 34(5):289-94. PubMed ID: 15556230
[TBL] [Abstract][Full Text] [Related]
10. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.
Cheung NK; Modak S; Vickers A; Knuckles B
Cancer Immunol Immunother; 2002 Nov; 51(10):557-64. PubMed ID: 12384807
[TBL] [Abstract][Full Text] [Related]
11. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
12. Correlation of structure to antitumor activities of five derivatives of a beta-glucan from Poria cocos sclerotium.
Wang Y; Zhang L; Li Y; Hou X; Zeng F
Carbohydr Res; 2004 Oct; 339(15):2567-74. PubMed ID: 15476718
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
14. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.
Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M
Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
[TBL] [Abstract][Full Text] [Related]
16. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice.
Oshiman K; Fujimiya Y; Ebina T; Suzuki I; Noji M
Planta Med; 2002 Jul; 68(7):610-4. PubMed ID: 12142994
[TBL] [Abstract][Full Text] [Related]
17. Structure of pestalotan, a highly branched (1----3)-beta-D-glucan elaborated by Pestalotia sp. 815, and the enhancement of its antitumor activity by polyol modification of the side chains.
Misaki A; Kawaguchi K; Miyaji H; Nagae H; Hokkoku S; Kakuta M; Sasaki T
Carbohydr Res; 1984 Jul; 129():209-27. PubMed ID: 6547877
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activities of mitomycin C (1----3)-beta-D-glucan conjugate.
Nagai K; Tanaka J; Kiho T; Ukai S
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):986-9. PubMed ID: 1525956
[TBL] [Abstract][Full Text] [Related]
19. Dose, route, and time dependence of serum lysozyme and antitumor activity following administration of glucan, Corynebacterium parvum, pyran, or lipopolysaccharide to mice.
Gorecka-Tisera A; Proctor JW; Yamamura Y; Harnaha J; Meinert K
J Natl Cancer Inst; 1981 Oct; 67(4):911-5. PubMed ID: 6944557
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of beta-D-glucan from Libyan dates.
Ishurd O; Zgheel F; Kermagi A; Flefla M; Elmabruk M
J Med Food; 2004; 7(2):252-5. PubMed ID: 15298775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
